Efficacy News and Research

RSS

Associations between maternal COVID-19 vaccination and hospitalization among infants

Researchers assessed the efficacy of maternal mRNA vaccinations during pregnancy against hospitalization for COVID-19 in infants aged <6 months.

24 Jun 2022

New nanoparticles effectively stopped the growth and spread of ovarian, liver tumors in mice

As they grow, solid tumors surround themselves with a thick, hard-to-penetrate wall of molecular defenses. Getting drugs past that barricade is notoriously difficult.

24 Jun 2022

Fragment crystallizable-altered COVID-19 antibodies efficacious across two animal models

A recent article posted to the bioRxiv* preprint server identified numerous efficacious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies from convalescent SARS-CoV-2 patients.

23 Jun 2022

Researchers continue a national study to evaluate COVID-19 vaccination safety pre-and post-delivery

With the SARS-CoV-2 pandemic ongoing, researchers at University of California San Diego School of Medicine, in collaboration with the American Academy of Allergy Asthma and Immunology, will continue a national study to evaluate the safety of COVID-19 vaccinations during pregnancy, and monitor immune response for mother and baby following vaccinations.

23 Jun 2022

Addressing parents' hesitancy to vaccinate their children against COVID

Researchers examine notable risk factors related to vaccine hesitancy among parents.

23 Jun 2022

Correlates of anamnestic humoral immunity throughout SARS-CoV-2 variants of concern

A recent work posted to the bioRxiv* preprint server assessed the indicators of anamnestic humoral immunity among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs).

23 Jun 2022

Research assesses ability of SARS‐CoV‐2‐neutralising mAbs to prevent COVID‐19

In a recent study published in the Cochrane Library, researchers searched multiple databases to identify randomized controlled trials (RCTs) that evaluated severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)‐neutralizing monoclonal antibodies (mAbs).

23 Jun 2022

Analyzing biophysical restrictions of SARS-CoV-2 N-terminal domain

In a recent article posted to the bioRxiv* preprint server, researchers at the University of Illinois at Urbana-Champaign, Scripps Research Institute, and Case Western Reserve University evaluated the biophysical limitations of the spike (S) N-terminal domain (NTD) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

23 Jun 2022

Lung cancer patients treated with immune checkpoint inhibitors can be safely vaccinated against COVID-19, study says

Cancer patients have received priority status to receive COVID-19 vaccinations but there is limited data regarding the safety and efficacy of the vaccines for patients treated for lung cancer with immune checkpoint inhibitors.

22 Jun 2022

RUDN doctors propose an alternative method of surgical management of glaucoma

RUDN University doctors have proposed an alternative method of surgical management of glaucoma. The main risk factor of glaucoma is increased pressure in the eye.

22 Jun 2022

Preclinical study unlocks the promise of CAR T-cell therapy for treatment of solid tumors

Scientists at St. Jude Children's Research Hospital identified a molecular mechanism that in a preclinical study unlocked the promise of CAR T–cell therapy for treatment of solid tumors.

22 Jun 2022

Scientists evaluate JNK inhibitors in treating moderate to severe COVID-19 patients

Scientists have described the clinical outcomes in hospitalized COVID-19 patients who have been treated with JNK inhibitors together with standard of care.

22 Jun 2022

The role of smartphone apps during the COVID-19 pandemic

In a recent study published in Nature Biotechnology, researchers assessed the role of smartphone apps during the coronavirus disease 2019 (COVID-19) pandemic.

22 Jun 2022

New perspectives on C-section and microbiota in newborns

A new study pinpoints key questions and knowledge gaps that must be addressed in order to define microbiome deficits and their link to health outcomes in infants born by Cesarian section, but also to evaluate adequate clinical intervention strategies in this population.

22 Jun 2022

Researchers map cancer driver mutations across the human genome

In a recent study published in Nature Biotechnology, researchers explored the causes of cancer by mapping somatic mutation rates across the human genome.

22 Jun 2022

New technology can revitalize the bactericidal effects of conventional antibiotics in MDR E.coli infections

A research team led by Professor Kelvin Yeung Wai-kwok from the Department of Orthopaedics and Traumatology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong (HKUMed) has designed a non-invasive technology to revitalize the bactericidal effects of conventional antibiotics in multidrug-resistant (MDR)Escherichia coli (E. coli)-associated deep tissue infections, such as urinary tract and peritoneal infections.

22 Jun 2022

Efficacy News and Research

Associations between maternal COVID-19 vaccination and hospitalization among infants

New nanoparticles effectively stopped the growth and spread of ovarian, liver tumors in mice

Fragment crystallizable-altered COVID-19 antibodies efficacious across two animal models

Researchers continue a national study to evaluate COVID-19 vaccination safety pre-and post-delivery

Addressing parents' hesitancy to vaccinate their children against COVID

Correlates of anamnestic humoral immunity throughout SARS-CoV-2 variants of concern

Research assesses ability of SARS‐CoV‐2‐neutralising mAbs to prevent COVID‐19

Analyzing biophysical restrictions of SARS-CoV-2 N-terminal domain

Lung cancer patients treated with immune checkpoint inhibitors can be safely vaccinated against COVID-19, study says

RUDN doctors propose an alternative method of surgical management of glaucoma

Preclinical study unlocks the promise of CAR T-cell therapy for treatment of solid tumors

Scientists evaluate JNK inhibitors in treating moderate to severe COVID-19 patients

The role of smartphone apps during the COVID-19 pandemic

New perspectives on C-section and microbiota in newborns

Researchers map cancer driver mutations across the human genome

New technology can revitalize the bactericidal effects of conventional antibiotics in MDR E.coli infections

Erectile dysfunction drugs may be able to boost the effect of chemotherapy in esophageal cancer

Computer simulation model helps understand why chemotherapy resistance occurs

New screening tool could increase the number of tests on solid tumor sample by up to 50 times

Wistar scientists discover a new way to boost a person's immune response to tumors

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News